WATERTOWN, Mass., Nov. 2, 2016 /PRNewswire/ -- Dynasil Corporation
of America (NASDAQ: DYSL) today announced that its subsidiary, RMD
Inc., will be supplying Thermo Fisher Scientific with packaged
solid state detectors based on RMD's
Cs2LiYCl6:Ce (CLYC) scintillation crystals
for use in Thermo's new RadEye SPRD-GN spectroscopic personal
radiation detectors.
Security professionals seeking reliable radiation detection and
identification for remote locations can now use Thermo Scientific's
pocket-size search-and-find detector that is designed for
high-sensitivity and accuracy. Utilizing CLYC, the new
detector provides both gamma and neutron detection, enabling first
responders to quickly locate and identify a wide range of
radioactive materials with a single device.
CLYC can distinguish gamma-ray and neutron radiation using pulse
height discrimination (PHD) as well as more powerful pulse shape
discrimination (PSD) and the RadEye SPRD-GN utilizes these powerful
capabilities of CLYC. CLYC is also capable of high resolution
gamma ray spectroscopy. This feature enables the RadEye
SPRD-GN to provide accurate identification of the detected
radiation.
"RMD's world-class research and manufacturing in nuclear
detection continues to be on the cutting edge of new technologies,"
said Kanai Shah, Ph. D., President
of Dynasil's RMD subsidiary. "For the past several years, RMD
has collaborated with our OEM partner Thermo Fisher Scientific on
the development of this RadEye SPRD product, a state of the art
instrument for radiation detection. CLYC is an example of our
research transitioning into products that make a real world
difference in protecting the United
States from illicit nuclear materials."
About Dynasil
Dynasil Corporation of America (NASDAQ:
DYSL) develops and manufactures detection and analysis technology,
precision instruments and optical components for the homeland
security, medical and industrial markets. Combining world-class
technology with expertise in research and materials science,
Dynasil is commercializing products including dual-mode radiation
detection solutions for Homeland Security and commercial
applications, probes for medical imaging and sensors for
non-destructive testing. Dynasil has an impressive and growing
portfolio of issued and pending U.S. patents. The Company is based
in Watertown, Massachusetts, with
additional operations in Mass., Minn., NY, NJ and the United Kingdom. More information about the
Company is available at www.dynasil.com.
Forward-looking Statements
This news release may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements regarding future events and our
future results are based on current expectations, estimates,
forecasts, and projections and the beliefs and assumptions of our
management. These forward-looking statements may be identified by
the use of words such as "may," "could," "expect," "estimate,"
"anticipate," "continue" or similar terms, though not all
forward-looking statements contain such words. The actual results
of the future events described in such forward-looking statements
could differ materially from those stated in such forward-looking
statements due to a number of important factors. These factors that
could cause actual results to differ from those anticipated or
predicted include, without limitation, our ability to develop and
commercialize our products, including our dual mode detectors and
the development of new technologies including at Dynasil
Biomedical, the size and growth of the potential markets for our
products and our ability to serve those markets, the rate and
degree of market acceptance of any of our products, general
economic conditions, costs and availability of raw materials and
management information systems, our ability to obtain and maintain
intellectual property protection for our products, competition, the
loss of key management personnel, litigation, the effect of
governmental regulatory developments, the availability of financing
sources, our ability to identify and execute on acquisition
opportunities and integrate such acquisitions into our business,
and seasonality, as well as the uncertainties set forth in the
Company's Annual Report on Form 10-Kand from time to time in the
Company's other filings with the Securities and Exchange
Commission. The Company disclaims any intention or obligation to
update any forward-looking statements, whether as a result of new
information, future events or otherwise.
Contact:
Patty Kehe
Dynasil Corporation of America
Phone: 617.668.6855
Email: pkehe@dynasil.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dynasils-rmd-subsidiary-supplying-thermo-fisher-scientific-with-clyc-for-new-radeye-sprd-gn-detector-300355732.html
SOURCE Dynasil Corporation of America